Antimicrobial therapy may cause changes in the resident oral microbiota, with the increase of opportunistic pathogens. The aim of this study was to compare the prevalence of Candida, Staphylococcus, Pseudomonas and Enterobacteriaceae in the oral cavity of fifty patients undergoing antibiotic therapy for pulmonary tuberculosis and systemically healthy controls. Oral rinsing and subgingival samples were obtained, plated in Sabouraud dextrose agar with chloramphenicol, mannitol agar and MacConkey agar, and incubated for 48 h at 37 o C. Candida spp. and coagulase-positive staphylococci were identified by phenotypic tests, C.
INTRODUCTION

Tuberculosis is a chronic infectious disease caused by
Mycobacterium tuberculosis or other pathogenic mycobacteria of the Mycobacterium tuberculosis complex. The disease continues to be an important public health problem in various countries. Infection with human immunodeficiency virus (HIV), injection drug use, increased poverty, migration, malnutrition and urbanization have contributed to the increase in the number of tuberculosis cases worldwide (9) . As mycobacteria are able to develop resistance to single-drug regimens, the treatment of choice is based on the use of multiple antimicrobial agents administered over a period of 6 to 12 months (25) . 
br Opportunistic microorganisms in tuberculosis patients
There is evidence indicating that the long-term use of antibiotics might be related to alterations in the resident oral microbiota and to a possible increase in the occurrence of opportunistic microorganisms (22) , as enteric bacilli, Pseudomonas, Staphylococcus and yeasts (7, 19) .
Candida spp. is present in the oral cavity and is considered a commensal fungi. C. albicans is the predominant species, accounting for 60 to 70% of all isolations, followed by C. tropicalis and C. glabrata (2, 12, 26) . The incidence of Candida spp. in the oral cavity and the reasons for the establishment of infections caused by these microorganisms have been associated to immunosuppression, endocrine disorders, mucosal lesions, poor oral hygiene, and long-term treatment with antibiotics or corticosteroids (3, 13) .
Bacteria of the families Enterobacteriaceae and
Pseudomonas spp. have been extensively studied and, although these bacteria are not considered pathogenic in healthy human, the oral cavity may serve as a reservoir for these microorganisms and may seriously compromise the life of debilitated individuals (19, 10, 23) .
Microorganisms of the genus staphylococci are not considered part of the resident human oral microflora, but may act as opportunistic pathogens in patients undergoing prolonged systemic treatment with antimicrobial agents or immunosuppressors (1, 17) .
Several lines of evidence indicate that the prolonged use of antibiotics and host-related factors are associated with alterations in the resident oral microbiota and with a possible increase in the occurrence of opportunistic microorganisms.
Therefore, the objective of the present study was to compare the prevalence of Candida, Enterobacteriaceae, Staphylococcus and Pseudomonas in the oral cavity and gingival sites in the oral cavity of patients undergoing antibiotic therapy for pulmonary tuberculosis and healthy controls.
MATERIALS AND METHODS
The study was approved by the Ethics Committee of the The oral rinse samples were centrifuged for 10 min at 8,000 g and the supernatant was discarded. Next, 2. Staphylococcus spp. isolates were tested for catalase and coagulase production. Positive strains were identified by acid production from D-trehalose and the Voges-Proskauer test.
Coagulase-negative staphylococci were identified using the API Staph system (bioMérieux, France). The
Enterobacteriaceae and Pseudomonas spp. isolates were identified using the API 20E system (bioMérieux).
The results were compared statistically by ANOVA and the Mann-Whitney test, at the level of significance of 5%.
RESULTS
At the time of sample collection, 19 (38%) patients of the tuberculosis group were in the first phase of treatment, receiving a combination of rifampicin, isoniazid and pyrazinamide, and 31 (62%) were in the second phase of treatment, receiving a combination of rifampicin and isoniazid.
Candida spp. was more prevalent in the oral cavity of the tuberculosis patients, than control individuals, for both analyzed samples (Table 1) . Candida counts were also significantly higher in the oral cavity (3.61 log CFU/ml) and gingival sites (2.62 log CFU/ml) of patients with tuberculosis, compared to controls (3.16 log CFU/ml and 0,69 log CFU/ml, respectively) (p=0.0085 and p=0.0103, respectively).
From Candida positive individuals, 73 different strains of the yeasts were isolated from tuberculosis patients and 33, from the control group. C. albicans was the most frequently isolated species in both groups, followed by C. tropicalis. A greater Opportunistic microorganisms in tuberculosis patients diversity of Candida isolates was observed in the tuberculosis group compared to the control subjects (Table 2 ). C.
dubliniensis was not detected in both groups.
The prevalence of Staphylococcus spp. was slightly higher in the oral cavity of tuberculosis group. In the gingival sites, Staphylococcus spp. was more prevalent among control subjects than among patients with tuberculosis ( Table 4 . Regarding the species identified, C. albicans was the most frequently isolated species in both groups, followed by C.
tropicalis. C. albicans was isolated from 60.8% of patients with tuberculosis, in agreement with other studies showing that C. albicans is the predominant species in the oral cavity, accounting for 60 to 70% of all isolations (10), followed by C.
tropicalis (21, 26) . However, in contrast to other authors who reported C. glabrata to be the third most prevalent species after C. albicans and C. tropicalis, in the present study C.
parapsilosis was the third most frequent species, isolated from 4.4% of patients with pulmonary tuberculosis. C. glabrata was detected in only 1.7% of patients, a rate lower than the 7 to 24% reported by various studies (4, 26) .
Another finding of the present study was the greater diversity of Candida species in patients with pulmonary tuberculosis. These results agree with previous studies reporting higher prevalence of non-albicans species in patients with different predisposing factors (13, 2) . Probably, the imbalance in the microbiota favored the adherence of other species of Candida, which normally would not be able to adhere.
In the present study, the prevalence of Staphylococcus spp. was high in both groups (96% in the tuberculosis group and 92% in the control group). These rates are higher than the Although higher prevalence of Staphylococcus spp. and enterobacteria were observed in tuberculosis patients, the differences were not significant, as observed with Candida spp.
Some patients were receiving a combination of rifampicin, isoniazid and pyrazinamide, and others just rifampicin and isoniazid. Except rifampicin, the other antibiotics are very specific to mycobacteria, having no effect against other groups of bacteria. Probably, that is why the amounts of In conclusion, the present study suggests that the antimicrobial therapy for pulmonary tuberculosis induced significant increase in the amounts of Candida spp. and changes in diversity of species of all opportunistic microorganisms studied.
